Abdelfattah M.S.; Badr S.E.A.; Lotfy S.A.; Attia G.H.; Aref A.M.; Abdel Moneim A.E.; Kassab R.B.
(Springer, 2020)
Systemic administration of 3-nitropropionic acid (3-NPA) is commonly used to induce Huntingtons disease (HD)-like symptoms in experimental animals. Here, the potential neuroprotective efficiency of rutin and selenium (RSe) ...